KRAS inhibitor-10
Modify Date: 2024-01-11 15:22:58
KRAS inhibitor-10 structure
|
Common Name | KRAS inhibitor-10 | ||
|---|---|---|---|---|
| CAS Number | 2578876-75-0 | Molecular Weight | 519.63 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H37N3O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of KRAS inhibitor-10KRAS inhibitor-10 selectively and effectively inhibit RAS proteins, and particularly KRAS proteins. KRAS inhibitor-10 is an orally active anti-cancer agent and can be used for cancer research, such as pancreatic cancer, breast cancer, multiple myeloma, leukemia and lung cancer. KRAS inhibitor-10 is a tetrahydroisoquinoline compound (compound 11) extracted from patent WO2021005165 A1. |
| Name | KRAS inhibitor-10 |
|---|
| Description | KRAS inhibitor-10 selectively and effectively inhibit RAS proteins, and particularly KRAS proteins. KRAS inhibitor-10 is an orally active anti-cancer agent and can be used for cancer research, such as pancreatic cancer, breast cancer, multiple myeloma, leukemia and lung cancer. KRAS inhibitor-10 is a tetrahydroisoquinoline compound (compound 11) extracted from patent WO2021005165 A1. |
|---|
| Molecular Formula | C30H37N3O5 |
|---|---|
| Molecular Weight | 519.63 |